Effectiveness of community-based oral antiviral treatments against severe COVID-19 outcomes in people 70 years and over in Victoria, Australia, 2022: an observational study
Van Heer C, Majumdar SS, Parta I, Martinie M, Dawson R, West D, Hewett L, Lister D, Sutton B, O’Brien DP, Cowie BC
COVID-19
Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial.
Nyang'wa BT, Berry C, Kazounis E, Motta I, Parpieva N, Tigay Z, Moodliar R, Dodd M, Solodovnikova V, Liverko I, Rajaram S, Rassool M, McHugh T, Spigelman M, Moore DA, Ritmeijer K, du Cros P, Fielding K on behalf of the TB-PRACTECAL team
Global Infectious Disease Threats Tuberculosis (TB)
Person-centred care in TB.
Horter S, Daftary A, Keam T, Bernays S, Bhanushali K, Chavan D, Denholm J, Furin J, Jaramillo E, Khan A, Lin YD, Lobo R, Loveday M, Majumdar SS, Mistry N, Patel H, Rane S, Swaminathan A, Triasih R, Venkatesan N, Viney K, du Cros P
Beyond patient delay, navigating structural health system barriers to timely care and treatment in a high burden TB setting in Papua New Guinea.
Jops P, Cowan J, Kupul M, Trumb RN, Graham SM, Bauri M, Nindil H, Bell S, Keam T, Majumdar S, Pomat W, Marais B, Marks GB, Kaldor J, Vallely A, Kelly-Hanku A
Contact screening and management in a high-transmission MDR-TB setting in Papua New Guinea: Progress, challenges and future directions
Majumdar SS, Islam S, Lin Huang K, Morris L, Bauri M, Chan C, Kama G, Keam T, Peacock-Smith A, Finch S et al.
Tuberculosis (TB)
COVID-19 and its impacts on primary health services and public health infectious disease programs in Papua New Guinea. (PUBLIC HEALTH REPORT),
Newland J, Neuendorf N, , Vallely L, Mek A, Vengiau G, Farquhar R, Boli-Neo R, Seymour M, Wratten M, Aeno H, Nake Trumb R, Kerry Z, Huang KL, Maalsen A, Homer C, Robinson L, , Majumdar S, Vallely A, Laman M, Pomat W, Kelly-Hanku A
COVID-19 Global Infectious Disease Threats Maternal, Newborn + Child Health